Luc Van Kaer

Active 1990–2025

122
Papers
21,941
Citations
90
h-index
120
i10-index

Citations

Citations per year for Luc Van Kaer1932: 1 citations1991: 10 citations1992: 8 citations1993: 14 citations1994: 49 citations1995: 68 citations1996: 70 citations1997: 78 citations1998: 92 citations1999: 151 citations2000: 197 citations2001: 263 citations2002: 299 citations2003: 356 citations2004: 343 citations2005: 396 citations2006: 244 citations2007: 269 citations2008: 233 citations2009: 222 citations2010: 250 citations2011: 201 citations2012: 205 citations2013: 172 citations2014: 180 citations2015: 139 citations2016: 107 citations2017: 142 citations2018: 131 citations2019: 359 citations2020: 391 citations2021: 444 citations2022: 432 citations2023: 290 citations2024: 413 citations2025: 185 citations2026: 4 citations1933–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,528 citing papers, 33.2% of this breakdownChina: 776 citing papers, 10.2% of this breakdownUnited Kingdom: 473 citing papers, 6.2% of this breakdownGermany: 453 citing papers, 6% of this breakdownJapan: 437 citing papers, 5.7% of this breakdownFrance: 341 citing papers, 4.5% of this breakdownAustralia: 269 citing papers, 3.5% of this breakdownCanada: 241 citing papers, 3.2% of this breakdownItaly: 232 citing papers, 3.1% of this breakdownNetherlands: 170 citing papers, 2.2% of this breakdownSwitzerland: 148 citing papers, 2% of this breakdownSweden: 136 citing papers, 1.8% of this breakdown
0%33.2%Other 18.4%

Fields

  • Immunology and Microbiology48.9%
  • Medicine28.7%
  • Biochemistry, Genetics and Molecular Biology16.2%
  • Neuroscience3.9%
  • Agricultural and Biological Sciences0.5%
  • Pharmacology, Toxicology and Pharmaceutics0.5%
  • Other1.3%

Topics

  • Immune Cell Function and Interaction15.4%
  • T-cell and B-cell Immunology10.6%
  • Immunotherapy and Immune Responses6%
  • IL-33, ST2, and ILC Pathways3%
  • CAR-T cell therapy research2.4%
  • Immune Response and Inflammation1.8%
  • Other60.8%

Coauthors

All papers

Open in search
  1. PD-1 up-regulation on CD4 + T cells promotes pulmonary fibrosis through STAT3-mediated IL-17A and TGF-β1 production

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2018 cited by 366

  2. Neuroblast senescence in the aged brain augments natural killer cell cytotoxicity leading to impaired neurogenesis and cognition

    Authors: , , , , , , - Nature Neuroscience 2020 cited by 185

  3. Intestinal Intraepithelial Lymphocytes: Sentinels of the Mucosal Barrier

    Authors: , - Trends in Immunology 2017 cited by 253

  4. NKT cells: what's in a name?

    Authors: , , , , - Nature reviews. Immunology 2004 cited by 1,171

  5. IL-10–producing B cells are enriched in murine pericardial adipose tissues and ameliorate the outcome of acute myocardial infarction

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 cited by 110

  6. NKG2A Is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple-Negative Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2023 cited by 63

  7. Organ-specific features of natural killer cells

    Authors: , , , - Nature reviews. Immunology 2011 cited by 400

  8. Autophagy-related protein PIK3C3/VPS34 controls T cell metabolism and function

    Authors: , , , , , , , - Autophagy 2020 cited by 74

  9. IL-33 promotes the egress of group 2 innate lymphoid cells from the bone marrow

    Authors: , , , , , , , , , - The Journal of Experimental Medicine 2017 cited by 182

  10. Targeted colonic claudin-2 expression renders resistance to epithelial injury, induces immune suppression, and protects from colitis

    Authors: , , , , , , , , , , , - Mucosal Immunology 2014 cited by 162

  11. Immunoproteasome Assembly: Cooperative Incorporation of Interferon γ (IFN-γ)–inducible Subunits

    Authors: , , , , , , - The Journal of Experimental Medicine 1998 cited by 445

  12. Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE

    Authors: , , , , - Cellular and Molecular Immunology 2019 cited by 144

  13. Impaired Autophagy, Defective T Cell Homeostasis, and a Wasting Syndrome in Mice with a T Cell–Specific Deletion of Vps34

    Authors: , , , , , , , , , - The Journal of Immunology 2013 cited by 159

  14. Neural stem cells sustain natural killer cells that dictate recovery from brain inflammation

    Authors: , , , , , - Nature Neuroscience 2016 cited by 118

  15. Mycobacterium tuberculosis Controls MicroRNA-99b (miR-99b) Expression in Infected Murine Dendritic Cells to Modulate Host Immunity

    Authors: , , , , , , , , , - Journal of Biological Chemistry 2012 cited by 171

  16. Development, Homeostasis, and Functions of Intestinal Intraepithelial Lymphocytes

    Authors: , - The Journal of Immunology 2018 cited by 96

  17. TAP1 mutant mice are deficient in antigen presentation, surface class I molecules, and CD4−8+ T cells

    Authors: , , , - Cell 1992 cited by 733

  18. The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells

    Authors: , , , , , , , , , , , , - The Journal of Experimental Medicine 1999 cited by 620

  19. Critical contribution of liver natural killer T cells to a murine model of hepatitis

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2000 cited by 538

  20. Central nervous system (CNS)–resident natural killer cells suppress Th17 responses and CNS autoimmune pathology

    Authors: , , , , , , , , , - The Journal of Experimental Medicine 2010 cited by 210

  21. IL-15 Regulates Homeostasis and Terminal Maturation of NKT Cells

    Authors: , , , , , , , , , , , - The Journal of Immunology 2011 cited by 163

  22. Natural killer T cells in health and disease

    Authors: - Frontiers in Bioscience-Scholar 2010 cited by 111

  23. Immune Privilege

    Authors: , - The Journal of Experimental Medicine 1999 cited by 84

  24. PD-1/PD-L Blockade Prevents Anergy Induction and Enhances the Anti-Tumor Activities of Glycolipid-Activated Invariant NKT Cells

    Authors: , , , , , , , , - The Journal of Immunology 2009 cited by 193